Alkermes plc (ALKS) Financials

ALKS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 4.3 billion 2.5 billion
Dec. 31, 2025 2.5 billion 711.0 million
Sept. 30, 2025 2.3 billion 596.1 million
June 30, 2025 2.3 billion 628.2 million

ALKS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -169.8 million 36.3 million
Dec. 31, 2025 170.1 million -72.4 million
Sept. 30, 2025 84.4 million 24.7 million
June 30, 2025 137.2 million 25.0 million

ALKS Net Income

No data available :(

ALKS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 511.9 million 1.5 billion 71.3 million
Dec. 31, 2025 1.3 billion - 63.3 million
Sept. 30, 2025 1.1 billion - 71.6 million
June 30, 2025 1.0 billion - 72.7 million

ALKS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 166.2 million
Dec. 31, 2025 168.7 million
Sept. 30, 2025 168.5 million
June 30, 2025 168.4 million

ALKS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 4.1 million 103.3 million 264.6 million 155.6 million
Dec. 31, 2025 20000 93.0 million 187.2 million 120.3 million
Sept. 30, 2025 17.3 million 81.7 million 171.8 million 115.6 million
June 30, 2025 13.0 million 77.4 million 170.8 million 121.2 million

ALKS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 392.9 million 61.6 million
Dec. 31, 2025 384.5 million 46.2 million
Sept. 30, 2025 394.2 million 51.6 million
June 30, 2025 390.7 million 49.5 million

ALKS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ALKS

Price: $43.38

52 week price:
25.17
44.57

Payout Ratio Range:
-28.47%
29.06%

Earnings Per Share: 0.90 USD

P/E Ratio: 39.41

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Ireland

Volume: 283127

Ebitda: 39.2 million

Market Capitalization: 7.2 billion

Links: